Total worldwide sales of products used to diagnose and treat glaucoma amounted to $4.2 billion in 2008, and pharmaceuticals accounted for the lion’s share of these revenues. A number of devices are used to screen for and monitor glaucoma, however once diagnosed medications instead of surgery is the first line of treatment. As a rule, surgical devices are used only when medication therapy fails to achieve the desired result.
The Global Glaucoma Device Market is a leading industry source for glaucoma market estimates and projections, including data on glaucoma’s prevalence, access to glaucoma treatment, glaucoma device sales, unit demand, average pricing and revenues. The data included in our report is based on journal articles, information presented at major ophthalmic meetings, surveys of glaucoma specialists, interviews with company executives, and analysis of financial data.
Our Report is Organized into Key Areas and Includes:
· The global glaucoma market including a global demographic analysis, the epidemiology of glaucoma, treatment and techniques for glaucoma.
· Overview of the market for glaucoma treatment products covering diagnostic equipment such as tonometers, perimeters, scanning laser ophthalmoscopes (SLOs) and optical coherence tomography (OCT).
· Description and market analysis of ophthalmic laser market including photocoagulation and SLT lasers.
· Description and analysis of glaucoma drainage devices market.
· Description and analysis of single-use items market.
The report also profiles 31 companies involved in the production, development and marketing of glaucoma related products.
The 2008 Comprehensive Report on the Global Glaucoma Device Market is expected to be published in November 2008. Reports are printed in color and spiral bound for ease of reading. The price of the report is $2,650; additional copies are available for use within your company for $300 each.
Ophthalmic lasers are used to treat a wide variety of diseases and conditions, but these devices are primarily used to treat retinal disease, glaucoma, and a common complication to cataract surgery. Use of lasers to treat these ophthalmic conditions has been common practice for more than 20 years, and the last major technical progress was made in the mid 1990s with the introduction of diode lasers to replace the older gas lasers. Also, the introduction of the SLT laser, a treatment breakthrough employing a lower power, shorter pulse version of existing technology, has helped to grow the category.
Global demand for ophthalmic lasers (exclusive of excimer and femtosecond lasers) along with maintenance, accessories, and endoprobes is expected to grow at a compounded rate of 10.3 percent from 2008 to 2013. Demand will be based on expansion in access to advanced medical treatment (retinal surgery and glaucoma treatment) in the developing world and rapid growth in the segment of the global population over age 65 that has a high prevalence of retinal disease.
Our Comprehensive Report on the Global Ophthalmic Laser Market (exclusive of excimer and femtosecond lasers) is the leading industry source for accurate and relevant information on all aspects of the market. A table of contents is listed below.
The data included in our reports is based on surveys of ophthalmic surgeons, extensive reviews and analysis of clinical data, interviews with company executives and analysis of financial data.
The 2008 Comprehensive Report on the Global Ophthalmic Laser Market (exclusive of femtosecond and excimer) was published in October 2008 and is printed in color and spiral bound for ease of reading. The price of the report is $3,000; additional copies are available for use within your company for $300 each.